scispace - formally typeset
Open AccessJournal ArticleDOI

Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate

Reads0
Chats0
TLDR
It is found that RBD219-N1 exhibited high expression yield, and maintained its antigenicity and functionality, and more importantly, induced significantly stronger RBD-specific antibody responses and a higher level of neutralizing antibodies in immunized mice than RBD193-WT, RBD 193-N 1, R BD193-N3, or RBD 219-WT.
Abstract
Development of vaccines for preventing a future pandemic of severe acute respiratory syndrome (SARS) caused by SARS coronavirus (SARS-CoV) and for biodefense preparedness is urgently needed. Our pr...

read more

Citations
More filters
Journal ArticleDOI

Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine.

TL;DR: The receptor-binding domain (RBD) in SARS-CoV-2 S protein was identified and it was found that the RBD protein bound strongly to human and bat angiotensin-converting enzyme 2 (ACE2) receptors and could block the binding and, hence, attachment of SARs-Cov-2 RBD and SARS -CoV RBD to ACE2-expressing cells, thus inhibiting their infection to host cells.
Journal ArticleDOI

Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures.

TL;DR: The latest literatures on genetic, epidemiological, and clinical features of COVID‐19 in comparison to SARS and MERS are summarized and special measures on diagnosis and potential interventions are emphasized to improve understanding of the unique features ofCOVID‐ 19 and enhance control measures in the future.
Journal ArticleDOI

Coronavirus Infections in Children Including COVID-19: An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children.

TL;DR: Preliminary evidence suggests children are just as likely as adults to become infected with SARS-CoV-2 but are less likely to be symptomatic or develop severe symptoms, but the importance of children in transmitting the virus remains uncertain.
References
More filters
Journal ArticleDOI

Coronavirus as a possible cause of severe acute respiratory syndrome

TL;DR: Serological and molecular tests specific for the virus permitted a definitive laboratory diagnosis to be made and allowed further investigation to define whether other cofactors play a part in disease progression.
Journal ArticleDOI

Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor

TL;DR: The structure of the RBD suggests ways to make truncated disulfide-stabilized RBD variants for use in the design of coronavirus vaccines.
Journal ArticleDOI

The spike protein of SARS-CoV — a target for vaccine and therapeutic development

TL;DR: Recent advances in the development of vaccines and therapeutics based on the S protein are highlighted, which plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity, during infection with SARS-CoV.
Journal ArticleDOI

Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003

TL;DR: Genetic analysis showed that the SARS CoV isolates from Guangzhou shared the same origin with those in other countries, and had a phylogenetic pathway that matched the spread of SARS to the other parts of the world.
Journal ArticleDOI

A 193-Amino Acid Fragment of the SARS Coronavirus S Protein Efficiently Binds Angiotensin-converting Enzyme 2

TL;DR: It is demonstrated that a 193-amino acid fragment of the S protein bound ACE2 more efficiently than did the full S1 domain (residues 12–672) and a point mutation at aspartic acid 454 abolished association of the fullS1 domain and of the 193-residue fragment with ACE2.
Related Papers (5)